GenoType MTBDRplus
First Evaluation of GenoType MTBDRplus 2 0 Performed Directly on Respiratory Specimens in Central America
5
EVALUATION OF THE GENOTYPE MTBDRPLUS ASSAY FOR RIFAMPIN AND ISONIAZID SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS STRAINS IN SPUTUM SPECIME
12
Genotype MTBDRplus for Direct Detection of Mycobacterium tuberculosis and Drug Resistance in Strains from Gold Miners in South Africa
6
GenoType MTBDRplus Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Samples
8
Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens
6
Validation of the GenoType®MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam
8
Suitability of Xpert MTB/RIF and Genotype MTBDRplus for Patient Selection for a Tuberculosis Clinical Trial
5
Evaluation of genotype MTBDRplus VER 2 0 line probe assay for the detection of MDR TB in smear positive and negative sputum samples
8
Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance
7
Performance Assessment of the GenoType MTBDRplus Test and DNA Sequencing in Detection of Multidrug Resistant Mycobacterium tuberculosis
5
Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug resistant tuberculosis in Cameroon: a cross sectional study
10
The Diagnostic Performance of the GenoType MTBDRplus Version 2 Line Probe Assay Is Equivalent to That of the Xpert MTB/RIF Assay
5
Validation of the GenoType® MTBDRplus assay for detection of MDR TB in a public health laboratory in Thailand
6
Pathways to multidrug resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests
13
Original Article Diagnostic performance of GenoType MTBDR plus on culture specimens in smear-negative retreatment tuberculosis patients
5
Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso
8
Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplusassay and their implication for treatment outcomes in patients from Mumbai, India
8
Evaluation of the GenoType MTBDR<em>plus</em> and MTBDR<em>sl</em> for the detection of drug-resistant <em>Mycobacterium tuberculosis</em> on isolates from Beijing, China
8
Utility of Second Generation Line Probe Assay (Hain MTBDRplus) Directly on 2 Month Sputum Specimens for Monitoring Tuberculosis Treatment Response
8
Predictive Value of Molecular Drug Resistance Testing of Mycobacterium tuberculosis Isolates in Valle del Cauca, Colombia
5